Companies › TARA

PROTARA THERAPEUTICS INC (TARA)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001359931 · EDGAR filings · Updated 2026-07-07

PROTARA THERAPEUTICS INC (TARA) has reported institutional ownership of 84.2%, with 113 institutional managers holding positions valued at $237.4M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Latest updates

• 2026-07-07 — SCHEDULE 13G/A filed
• 2026-07-01 — Insider transaction reported (Form 4)
• 2026-06-29 — Current report (8-K) filed
• 2026-06-29 — Notice of proposed sale filed (Form 144)
• 2026-06-16 — Insider transaction reported (Form 4)
• 2026-06-16 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, PROTARA THERAPEUTICS INC has 113 institutional holders and institutional ownership of 84.2%.

Insider activity

Insiders reported 23 transactions (2 buys, 0 sells) across 7 reporting insiders, with a net reported value of $127.6K.

Data flags from SEC filings

Related companies

EIKON THERAPEUTICS INC (EIKN) · Immix Biopharma Inc (IMMX) · AGOMAB THERAPEUTICS NV (AGMB) · LYELL IMMUNOPHARMA INC (LYEL) · RXSIGHT INC (RXST) · STRATA CRITICAL MEDICAL INC (SRTA)